Noboru Kamada

402 citations
18 papers · 319 · h-index 12

Impact in

  • Organic Chemistry
    • Synthesis and biological activity
    • Synthesis and Biological Evaluation
    • Synthesis and Characterization of Heterocyclic Compounds
    • Multicomponent Synthesis of Heterocycles
  • Hepatology

Papers in

  • Molecular Biology 6
    • Pluripotent Stem Cells Research 3
  • Organic Chemistry 4
    • Synthesis and Characterization of Heterocyclic Compounds 3
    • Quinazolinone synthesis and applications 2
    • Synthesis and biological activity 2
Co-authors
Harunobu Mukaiyama (4 shared papers)Satoko Kobayashi (4 shared papers)Tomonaga Ozawa (4 shared papers)Yoshimitsu Komatsu (4 shared papers)Junji Kimura (1 shared paper)Den-ichi Momose (1 shared paper)Shinji Kikuchi (2 shared papers)Hideki Ohnota (3 shared papers)
Journals
Bioorganic & Medicinal Chemistry (7 papers)Drug Metabolism and Pharmacokinetics (2 papers)European Journal of Pediatrics (1 paper)Bioanalysis (1 paper)Biological and Pharmaceutical Bulletin (1 paper)
Partner nations
JapanUnited StatesCameroon

In The Last Decade

Noboru Kamada

18 papers receiving 315 citations

Peers

Noboru Kamada
Comparison fields: 5 of 65
  • Organic Chemistry 115
  • Hepatology 23
  • Sensory Systems 11
  • Toxicology 7
  • Endocrinology, Diabetes and Metabolism 32
Replace Heinz‐Werner Kleemann with:
Heinz‐Werner Kleemann Germany
Matti Lepistö Sweden
Guangyao Lv China
Soumya Sasi United States
Xiawen Liu China
Ahmed A.E. Mourad Egypt
Zeping Zuo China
Christopher Trabbic United States
Xiaonan Xi China
Noboru Kamada relative to Heinz‐Werner Kleemann Germany Heinz‐Werner Kleemann's profile →
Citations per field
00.5×2×3×3.5×
Heinz‐Werner Kleemann · 1×
Citations per year

Countries citing papers authored by Noboru Kamada

Since Specialization
Citations

This map shows the geographic impact of Noboru Kamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noboru Kamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noboru Kamada more than expected).

Fields of papers citing papers by Noboru Kamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noboru Kamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noboru Kamada. The network helps show where Noboru Kamada may publish in the future.

Co-authors

The 25 scholars most cited alongside Noboru Kamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Noboru Kamada Line = papers co-authored together Noboru Kamada links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
An Efficient Method for Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-like Cells Retaining Drug Metabolizing Activity
Drug Metabolism and Pharmacokinetics ·Yuki Kondo, Takahiro Iwao, Katsunori Nakamura, Takamitsu Sasaki, Shogo Takahashi, Noboru Kamada, Tsutomu Matsubara, Frank J. Gonzalez, Hidenori Akutsu, Yoshitaka Miyagawa, Hajime Okita, Nobutaka Kiyokawa, Masashi Toyoda, Akihiro Umezawa, Kiyoshi Nagata, Tamihide Matsunaga, Shigeru Ohmori
201351
2
Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke
Bioorganic & Medicinal Chemistry ·Harunobu Mukaiyama, Toshihiro Nishimura, Satoko Kobayashi, Tomonaga Ozawa, Noboru Kamada, Yoshimitsu Komatsu, Shinji Kikuchi, Hideki Oonota, Hiroshi Kusama
200641
3
Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade
Bioorganic & Medicinal Chemistry ·Harunobu Mukaiyama, Toshihiro Nishimura, Satoko Kobayashi, Yoshimitsu Komatsu, Shinji Kikuchi, Tomonaga Ozawa, Noboru Kamada, Hideki Ohnota
200736
4
Fourteen Chamigrane Derivatives from a Red Alga, Laurencia nidifica
Bulletin of the Chemical Society of Japan ·Junji Kimura, Noboru Kamada, Yoshikazu Tsujimoto
199929
5
Discovery of Novel 2-Anilinopyrazolo[1,5-a]pyrimidine Derivatives as c-Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke
Chemical and Pharmaceutical Bulletin ·Harunobu Mukaiyama, Toshihiro Nishimura, Hiroaki Shiohara, Satoko Kobayashi, Yoshimitsu Komatsu, Shinji Kikuchi, Eiichi Tsuji, Noboru Kamada, Hideki Ohnota, Hiroshi Kusama
200727
6
The Advantages of the Ussing Chamber in Drug Absorption Studies
SLAS DISCOVERY ·Yasumasa Gotoh, Noboru Kamada, Den-ichi Momose
200526
7
Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides
European Journal of Pharmacology ·Masahiro Hiratochi, Kazuya Tatani, Kazuo Shimizu, Yu Kuramochi, Norihiko Kikuchi, Noboru Kamada, Fumiaki Itoh, Masayuki Isaji
201218
8
Structure–activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia
Bioorganic & Medicinal Chemistry ·Nobuhiko Fushimi, Hideki Fujikura, Hiroaki Shiohara, Hirotaka Teranishi, Kazuo Shimizu, Shigeru Yonekubo, Kohsuke Ohno, Takashi Miyagi, Fumiaki Itoh, Toshihide Shibazaki, Masaki Tomae, Yukiko Ishikawa-Takemura, Takeshi Nakabayashi, Noboru Kamada, Tomonaga Ozawa, Susumu Kobayashi, Masayuki Isaji
201217
9
Synthesis of 2-(substituted methyl)quinolin-8-ols and their complexation with Sn(II)
Journal of the Chemical Society Perkin Transactions 1 ·Chitoshi Kitamura, Naoyuki Maeda, Noboru Kamada, Mikio Ouchi, Akio Yoneda
200014
10
Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)
Bioorganic & Medicinal Chemistry ·Nobuhiko Fushimi, Hirotaka Teranishi, Kazuo Shimizu, Shigeru Yonekubo, Kohsuke Ohno, Takashi Miyagi, Fumiaki Itoh, Toshihide Shibazaki, Masaki Tomae, Yukiko Ishikawa-Takemura, Takeshi Nakabayashi, Noboru Kamada, Yuji Yamauchi, Susumu Kobayashi, Masayuki Isaji
201213
11
Synthesis and optimization of novel α-phenylglycinamides as selective TRPM8 antagonists
Bioorganic & Medicinal Chemistry ·Jun’ichi Kobayashi, Hideaki Hirasawa, Tetsuji Ozawa, Tomonaga Ozawa, Hiroo Takeda, Yoshikazu Fujimori, Osamu Nakanishi, Noboru Kamada, Tetsuya Ikeda
201613
12
Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor
Bioorganic & Medicinal Chemistry ·Kazuo Shimizu, Hideki Fujikura, Nobuhiko Fushimi, Toshihiro Nishimura, Kazuya Tatani, Kenji Katsuno, Yoshikazu Fujimori, Shinjiro Watanabe, Masahiro Hiratochi, Takeshi Nakabayashi, Noboru Kamada, Koichi Arakawa, Hidemasa Hikawa, Isao Azumaya, Masayuki Isaji
202111
13
Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea
European Journal of Pediatrics ·Yuki Ogawa, Mitsuru Irikura, Yuka Kobaru, Mayu Tomiyasu, Yoshie Kochiyama, Mamiko Uriu, Yoichi Ishitsuka, Yuki Kondo, Eiji Yukawa, Noboru Kamada, Hitoshi Ohno, Toshio Yamazaki, Tetsumi Irie
20149
14
Evaluation of Human Embryonic Stem Cell-derived Hepatocyte-like Cells for Detection of CYP1A Inducers
Drug Metabolism and Pharmacokinetics ·Hiroyuki Tsuchiya, Tamihide Matsunaga, Kaori Aikawa, Noboru Kamada, Katsunori Nakamura, Hinako Ichikawa, Katsunori Sasaki, Shigeru Ohmori
20124
15
Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects
Bioorganic & Medicinal Chemistry ·Jun’ichi Kobayashi, Hideaki Hirasawa, Yoshikazu Fujimori, Osamu Nakanishi, Noboru Kamada, Tetsuya Ikeda, Akitoshi Yamamoto, Hiroki Kanbe
20204
16
Discovery of Novel 2‐Anilinopyrazolo[1,5‐a]pyrimidine Derivatives as c‐Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke.
ChemInform ·Harunobu Mukaiyama, Toshihiro Nishimura, Hiroaki Shiohara, Satoko Kobayashi, Yoshimitsu Komatsu, Shinji Kukuchi, Eiichi Tsuji, Noboru Kamada, Hideki Ohnota, Hiroshi Kusama
20072
17
Development and Validation of an LC–MS/MS Method for Simultaneously Determining Doxapram and Keto-Doxapram in Human Serum
Bioanalysis ·Yuki Suzuki, Noboru Kamada, Hitoshi Ohno, Yoshikazu Abe, Takuro Endo, Mamoru Kobayashi
20172
18
Differentiation of Monkey Embryonic Stem Cells to Hepatocytes by Feeder-Free Dispersion Culture and Expression Analyses of Cytochrome P450 Enzymes Responsible for Drug Metabolism
Biological and Pharmaceutical Bulletin ·Junya Maruyama, Tamihide Matsunaga, Satoshi Yamaori, Sakae Sakamoto, Noboru Kamada, Katsunori Nakamura, Shinji Kikuchi, Shigeru Ohmori
20122

About Noboru Kamada

Noboru Kamada is a scholar working on Molecular Biology, Organic Chemistry, Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Oncology, having authored 18 papers that have together received 319 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (3 papers), Diabetes Treatment and Management (3 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers), Phytochemicals and Antioxidant Activities (2 papers), Quinazolinone synthesis and applications (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Synthesis and biological activity (2 papers) and Natural Antidiabetic Agents Studies (2 papers). The work is most often cited by research in Organic Chemistry (115 citations), Hepatology (23 citations), Sensory Systems (11 citations), Toxicology (7 citations) and Endocrinology, Diabetes and Metabolism (32 citations). Noboru Kamada has collaborated with scholars based in Japan, United States and Cameroon. Frequent co-authors include Harunobu Mukaiyama, Satoko Kobayashi, Tomonaga Ozawa, Yoshimitsu Komatsu, Junji Kimura, Den-ichi Momose, Shinji Kikuchi, Hideki Ohnota, Hiroshi Kusama and Masayuki Isaji. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, European Journal of Pediatrics, Bioanalysis and Biological and Pharmaceutical Bulletin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heinz‐Werner KleemannBreakdown of academic impact, for papers by Matti LepistöBreakdown of academic impact, for papers by Guangyao LvBreakdown of academic impact, for papers by Soumya SasiBreakdown of academic impact, for papers by Xiawen LiuBreakdown of academic impact, for papers by Ahmed A.E. MouradBreakdown of academic impact, for papers by Zeping ZuoBreakdown of academic impact, for papers by Christopher TrabbicBreakdown of academic impact, for papers by Xiaonan Xi